TrialBMC research notes2019

Inflammatory markers response to citrulline supplementation in patients with non-alcoholic fatty liver disease: a randomized, double blind, placebo-controlled, clinical trial.

Zahra Darabi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.